Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  32 results for ""Wang X""

Your Filters

Language : chinese Subject : antineoplastic combined chemotherapy protocols Filter by : Author
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

[Combination of anlotinib and irinotecan in the second-line treatment of metastatic colorectal cancer: a multicenter phase 1/2 trial].

  • Authors : Zhang B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Wang X

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Jan 23; Vol. 45 (1), pp. 95-100.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].

  • Authors : Ou KP; Department of Medicine, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing 100122, China.; Li Q

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Neoadjuvant Therapy*/Neoadjuvant Therapy*/Neoadjuvant Therapy*/adverse effects ; Pyridines*/Pyridines*/Pyridines*/adverse effects

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Nov 23; Vol. 42 (11), pp. 966-971.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)].

  • Authors : Hu MM; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China.; Yuan QQ

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Chemoradiotherapy/Chemoradiotherapy/Chemoradiotherapy/*methods ; Esophageal Neoplasms/Esophageal Neoplasms/Esophageal Neoplasms/*drug therapy

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Aug 23; Vol. 42 (8), pp. 676-681.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].

  • Authors : Shen T; Women's Reproductive Health Laboratory of Zhejiang Province, Department of Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China.; Chen LL

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Gestational Trophoblastic Disease/Gestational Trophoblastic Disease/Gestational Trophoblastic Disease/*drug therapy ; Neoplasm Recurrence, Local/Neoplasm Recurrence, Local/Neoplasm Recurrence, Local/*drug therapy EMA-CO protocol

  • Source: Zhonghua fu chan ke za zhi [Zhonghua Fu Chan Ke Za Zhi] 2018 Jun 25; Vol. 53 (6), pp. 371-376.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 16210370R Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[A multicenter, large-sample, randomized clinical trial on improving the median survival time of advanced non-small cell lung cancer by combination of Ginseng Rg3 and chemotherapy].

  • Authors : Zhang Y; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.; Wang XQ

Subjects: Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Apr 23; Vol. 40 (4), pp. 295-299.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[Effect of neoadjuvant chemotherapy on nutritional status of locally advanced gastric cancer].

  • Authors : Deng G; Department of Oncology, Weifang People's Hospital, Shandong Weifang 261041, China. .; Qu J

Subjects: Neoadjuvant Therapy* ; Nutritional Status*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

  • Source: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [Zhonghua Wei Chang Wai Ke Za Zhi] 2018 Mar 25; Vol. 21 (3), pp. 331-335.Publisher: Zhongshan da xue Country of Publication: China NLM ID: 101177990 Publication Model: Print Cited Medium: Print ISSN: 1671-0274 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Efficacy and safety of IA regimen containing different doses of idarubicin in de-novo acute myeloid leukemia for adult patients].

  • Authors : Sun AN; Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou Institute of Blood and Marrow Transplantation, Suzhou 215006, China.; Tian XP

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Leukemia, Myeloid, Acute/Leukemia, Myeloid, Acute/Leukemia, Myeloid, Acute/*drug therapy; Adolescent

  • Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2017 Dec 14; Vol. 38 (12), pp. 1017-1023.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[Impact of adjuvant chemotherapy on the prognosis of hormone receptor negative breast cancer with residual lymph node disease after neoadjuvant chemotherapy].

  • Authors : Wang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing 100143, China.; He YJ

Subjects: Chemotherapy, Adjuvant* ; Neoadjuvant Therapy*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

  • Source: Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2017 May 30; Vol. 97 (20), pp. 1576-1579.Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Progress of Neoadjuvant Therapy Combined with Surgery in Non-small Cell
Lung Cancer].

  • Authors : Wang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II,
Peking University Cancer Hospital & Institute, Beijing 100142, China.; Wang X

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*surgery

  • Source: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2017 May 20; Vol. 20 (5), pp. 352-360.Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

[Difference analysis of chemotherapy efficacy among different primary tumor sites in metastatic colorectal cancer].

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy ; Fluorouracil/Fluorouracil/Fluorouracil/*therapeutic use

  • Source: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [Zhonghua Wei Chang Wai Ke Za Zhi] 2016 Oct 25; Vol. 19 (10), pp. 1119-1123.Publisher: Zhongshan da xue Country of Publication: China NLM ID: 101177990 Publication Model: Print Cited Medium: Print ISSN: 1671-0274 (Print)

Record details

Read More Add to Saved list
×
  • 1-10 of  32 results for ""Wang X""